These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 47268)
1. [Monoclonal gammapathy in the clinical diagnosis of internal diseases]. Hrncírová L Cas Lek Cesk; 1975 Jan; 114(3):70-5. PubMed ID: 47268 [No Abstract] [Full Text] [Related]
2. [Electrophoretic and immunoelectrophoretic aspects of non-myelomatous paraproteinemias]. Pulido E Minerva Med; 1969 Nov; 60(90):4464-78. PubMed ID: 4187875 [No Abstract] [Full Text] [Related]
3. [Differential diagnosis of multiple myeloma. Immunoelectrophoretic demonstration of paraproteinemias]. Ludwig H Med Klin; 1968 Mar; 63(10):372-8. PubMed ID: 4178299 [No Abstract] [Full Text] [Related]
4. [Importance of the diagnosis of monoclonal dysglobulinemia in medical practice]. Dorr R; Mateja F; Denave L Sem Hop; 1969 Dec; 45(51):3257-63. PubMed ID: 4189409 [No Abstract] [Full Text] [Related]
5. [The immunoperoxidase method. Application to the study of immunoglobulin producing cells in the bone marrow of patients with monoclonal gammopathies]. Scolari L; Masala C Boll Soc Ital Biol Sper; 1974 Apr; 50(8):549-55. PubMed ID: 4141900 [No Abstract] [Full Text] [Related]
6. Plasma cell dyscrasias. Current clinical and biochemical concepts. Am J Med; 1968 Feb; 44(2):256-69. PubMed ID: 4169716 [No Abstract] [Full Text] [Related]
7. Therapy of macroglobulinaemia. Comparison of the effect of therapy on the level of monoclonal immunoglobulins and on clinical symptoms in four cases of waldenström's macroglobulinaemia and one case of IgA myeloma. Pronk EA; Elkerbout F; Klein F; Radema H; Cleton FJ Acta Med Scand; 1969 Oct; 186(4):273-81. PubMed ID: 4190857 [No Abstract] [Full Text] [Related]
8. Significance of M-components in plasma cell myeloma and related disorders. Kano T Tohoku J Exp Med; 1970 Dec; 102(4):341-67. PubMed ID: 4101555 [No Abstract] [Full Text] [Related]
10. Technical aspects of the detection and characterization of immunoglobulin dyscrasis. Conway BP Health Lab Sci; 1972 Jul; 9(3):185-96. PubMed ID: 4625660 [No Abstract] [Full Text] [Related]
11. [Systematic follow up of "asymptomatic" monoclonal dysglobulinemias in blood donors]. Fine JM; Derycke C; Josso F Rev Fr Transfus; 1968 Jul; 11(2):113-27. PubMed ID: 4180286 [No Abstract] [Full Text] [Related]
12. [Immunochemical characterization of the L-chains and H-chains of monoclonal immunoglobulins in multiple myeloma, Waldenstrom's disease and heavy chain disease]. Tischendorf FW Med Welt; 1968 Nov; 46():2531-6. PubMed ID: 4183339 [No Abstract] [Full Text] [Related]
14. [So-called benign essential monoclonal gammapathy and immunocytoproliferative diseases. Considerations on the problem and case reports]. Fernandes D; Sportiello V; Pace M; Stefan C G Batteriol Virol Immunol; 1981; 74(1-6):163-80. PubMed ID: 6171470 [No Abstract] [Full Text] [Related]
15. [Principles of clinical immunology. V. Immunologic diagnosis. Gammapathies]. Kuratowka Z; Dwilewicz-Trojaczek J Pol Tyg Lek; 1978 Aug; 33(35):1381-5. PubMed ID: 101979 [No Abstract] [Full Text] [Related]
17. [Inflammatory rheumatisms and paraproteins excepting myeloma and Waldenström's disease. Study of 18 personal cases of this association]. Dryll A; Rousselet F; Ryckewaert A; Kahn MF; Duguet M; de Sèze S Sem Hop; 1969 Jul; 45(31):2135-47. PubMed ID: 4185011 [No Abstract] [Full Text] [Related]